Actress Dipika Kakar was diagnosed with stage two liver cancer in May last year. After undergoing surgery for the same, the actress was taking targeted therapy to treat it. However, a new cyst seems ...
The U.S. Food and Drug Administration (FDA) has approved a wearable medical device used in combination with a standard chemotherapy regimen for the treatment of adult patients with locally advanced ...
Pancreatic tumors may hijack the body’s nervous system by forming synapse-like connections that allow them to absorb neurotransmitters and fuel their growth. This newly uncovered mechanism points to a ...
Scientists have uncovered a hidden partnership between pancreatic cancer and the nervous system. Support cells in the pancreas lure nerve fibers, which then release signals that accelerate early ...
FDA approved Optune Pax for locally advanced pancreatic cancer with gemcitabine/nab-paclitaxel, marking the first new modality in decades for this nonresectable ...
FDA approved Optune Pax with gemcitabine/nab-paclitaxel, applying alternating electric fields to disrupt mitosis via abdominal arrays, expanding noninvasive, home ...
The FDA has approved a first-of-its-kind wearable electrical device — Optune Pax (Novocure) — for patients with locally advanced pancreatic cancer, in combination with gemcitabine and nab-paclitaxel.
Cancer in the pancreas (the bottom organ in red) often doesn’t cause symptoms until it has already spread to other organs. — AFP Your pancreas has important jobs to do. A large, tadpole-shaped gland ...
This image shows a test tumor from a CMV-infected mouse, treated with CMV peptides. Pink represents cell death. Credit: UC San Diego Health Sciences Researchers at the University of California San ...
The biochemist’s company, Vega Oncotargets, has toned down its message after the false expectations generated by the announcement of a promising experiment with 45 ‘cured’ mice More than a hundred ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results